Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China.
Yang T, Liu Y, Li L, Zheng Y, Wang Y, Su J, Yang R, Luo M, Yu C.
Cardiovasc Diabetol. 2022 Jun 3;21(1):93. doi: 10.1186/s12933-022-01531-7.
Proteomic signatures of type 2 diabetes predict the incidence of coronary heart disease.
Li Y, Li D, Lin J, Zhou L, Yang W, Yin X, Xu C, Cao Z, Wang Y.
Cardiovasc Diabetol. 2025 Mar 14;24(1):120. doi: 10.1186/s12933-025-02670-3.
Multiple triglyceride-derived metabolic indices and incident cardiovascular outcomes in patients with type 2 diabetes and coronary heart disease.
Tao S, Yu L, Li J, Huang L, Xue T, Yang D, Huang X, Meng C.
Cardiovasc Diabetol. 2024 Oct 14;23(1):359. doi: 10.1186/s12933-024-02446-1.
Coronary Heart Disease in Type 2 Diabetes Mellitus: Genetic Factors and Their Mechanisms, Gene-Gene, and Gene-Environment Interactions in the Asian Populations.
Zarkasi KA, Abdul Murad NA, Ahmad N, Jamal R, Abdullah N.
Int J Environ Res Public Health. 2022 Jan 6;19(2):647. doi: 10.3390/ijerph19020647.
Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions.
Chen J, Yin D, Dou K.
Cardiovasc Diabetol. 2023 Jun 22;22(1):146. doi: 10.1186/s12933-023-01875-8.
MicroRNA 155, Factor XIII and Type 2 Diabetes Mellitus and Coronary Heart Disease.
Ntanyane Phasha MA, Soma P, Rooy MV, Phulukdaree A.
Curr Diabetes Rev. 2023;19(6):e190822207740. doi: 10.2174/1573399819999220819144402.
Percutaneous coronary intervention versus coronary artery bypass grafting in patients with coronary heart disease and type 2 diabetes mellitus: Cumulative meta-analysis.
Xie Q, Huang J, Zhu K, Chen Q.
Clin Cardiol. 2021 Jul;44(7):899-906. doi: 10.1002/clc.23613. Epub 2021 Jun 5.
Disease patterns of coronary heart disease and type 2 diabetes harbored distinct and shared genetic architecture.
Xiao H, Ma Y, Zhou Z, Li X, Ding K, Wu Y, Wu T, Chen D.
Cardiovasc Diabetol. 2022 Dec 9;21(1):276. doi: 10.1186/s12933-022-01715-1.
Research update on the association between SFRP5, an anti-inflammatory adipokine, with obesity, type 2 diabetes mellitus and coronary heart disease.
Wang D, Zhang Y, Shen C.
J Cell Mol Med. 2020 Mar;24(5):2730-2735. doi: 10.1111/jcmm.15023. Epub 2020 Jan 31.
Optimisation of the management of patients with coronary heart disease and type 2 diabetes mellitus.
Wilson SH, Kennedy FP, Garratt KN.
Drugs Aging. 2001;18(5):325-33. doi: 10.2165/00002512-200118050-00003.
